Corrigendum to 'Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer' [Eur J Cancer 53 (2016) 51–64]

Authors :: Hui Zhao
Elena Ioana Braicu
Matthieu Moisse
Robert Zeillinger
Silvia Darb-Esfahani
Dominiek Smeets
Diether Lambrechts
Jalid Sehouli
Els M.J.J. Berns
Dan Cacsire Castillo-Tong
Els Van Nieuwenhuysen
Sandrina Lambrechts
Adriaan Vanderstichele
Ignace Vergote
Source :: European Journal of Cancer. 60:226
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Genetic heterogeneity
business.industry
MEDLINE
Cancer
medicine.disease
Internal medicine
medicine
Serous ovarian cancer
First line chemotherapy
business

Full Text Access

Tools